Vascular calcification and QT interval in incident hemodialysis patients

Journal of Nephrology

Volumn 22, Issue 6, 2009, Pages 694-698

  Di lorio, Biagio Raffaele ^a   Cucciniello, Emanuele ^a   Bellizzi, Vincenzo ^a  

^a Renal Unit   (Italy)

Author keywords

Cardiac calcification; Hemodialysis incident patients; QT interval

Indexed keywords

ALUMINUM HYDROXIDE; CALCIMIMETIC AGENT; CALCIUM ACETATE; CALCIUM CARBONATE; PHOSPHATE BINDING AGENT; SEVELAMER; VITAMIN D;

ARTERIAL STIFFNESS; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HEMODIALYSIS PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; QT DISPERSION; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL;

ARRHYTHMIAS, CARDIAC; BIOLOGICAL MARKERS; CALCINOSIS; CALCIUM; CARDIOVASCULAR DISEASES; CHELATING AGENTS; ELECTROCARDIOGRAM PATTERN; HUMANS; KIDNEY FAILURE, CHRONIC; PHOSPHATES; POLYAMINES; PROSPECTIVE STUDIES; RENAL DIALYSIS; RESEARCH DESIGN; TIME FACTORS; TREATMENT OUTCOME;

EID: 72149104082     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kalantar-Zadeh K, Block G, Humphries M, et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63:793-808.
2. Stenvinkel P, Pecotis-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol. 2003;14:1927-1939.
3. Shik J, Parfrey PS. The clinical epidemiology of cardiovascular disease in chronic kidney disease. Curr Opin Nephrol Hypertens. 2004;14:550-557.
4. Tonelli M, Sacks F, Pfeffer M, et al. Relation between serum phosphate and cardiovascular event rate in people with coronary disease. Circulation. 2005;112:2627-2633.
5. Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034-2047.
6. London G, Guerin A, Marchais S, et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18:1731-1740.
7. Wang AY, Wang M, Ho S, et al. Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in endstahe renal disease. Arch Intern Med. 2005;165:327-332.
8. Floege J, Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant. 2004;19(S5):59-66.
9. Kettelr M, Westenfeld R, Schlieper G, Brandeburg V. Pathogenesis of vascular calcification in dialysis patients. Clin Exp Nephrol. 2005;9:265-270.
10. Di Iorio B, Bortone S, Piscopo C. Cardiac vascular calcification and Q-T interval in ESRD patients: is there a link? Blood Purif 2007
11. Chertow G, Burke S, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in haemodialysis patients. Kidney Int. 2002;62:245-252.
12. Di Iorio B, Bortone S, Piscopo C. Progression of vascular calcification increases QT interval in hemodialysis patients. Nephrol Dial Transplant. 2007;22:955-956.
13. Lee KW, Kligfield P, Okin PM, Dower GE. Determinants of precordial QT dispersion in normal subjects. J Electrocardiol. 1998;31:S128-S133.
14. Straus SMJM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47:362-367.
15. Elming H, Holm E, Jun L, et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J. 1998;19:1391-1400.
16. Dekker JM, Schouten EG, Klootwijk P, et al. Association between QT interval and coronary heart disease in middle aged and elderly men. The Zupten study. Circulation. 1994;90:779-785.
17. Schouten EG, Dekker JM, Meppelink P, et al. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation. 1991;84:1516-1523.
18. Montanez A, Ruskin JN, Hebert PR. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population. Arch Intern Med. 2004;164:943-948.
19. Beaubien ER, Pylypchuk GB, Akhtar J, Biem HJ. Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality. Am J Kidney Dis. 2002;39:834-842.
20. Agatston A, Janowitz W, Hildner F, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-832.
21. Covic A, Mardare N, Gusbeth-Tatomir P, et al. Arterial wave reflections and mortality in hemodialysis patients: only relevant in elderly, cardiovascularly compromised? Nephrol Dial Transplant. 2006;21:2859-2866.
22. Chesterton LJ, Sigrist MK, Bennett T, et al. Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant. 2005;20:1140-1147.
23. Moriya H, Ohtake T, Kpbayashi S. Aortic stiffness, left ventricular hypertrophy and weekly averaged blood pressure in patients on hemodialysis. Nephrol Dial Transplant. 2007;22:1198-1204.